IL6 and inflammatory bowel disease: Pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) are elevated in IBD patients and can promote hepatic steatosis through multiple mechanisms, including increased hepatic lipogenesis, decreased fatty acid oxidation, and insulin resistance.